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Energy-dense diets increase FGF23, 
lead to phosphorus retention and 
promote vascular calcifications in 
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Rats with normal renal function (Experiment 1, n = 12) and uninephrectomized (1/2Nx) rats 
(Experiment 2, n = 12) were fed diets with normal P (NP) and either normal (NF) or high fat (HF). 
Rats with intact renal function (Experiment 3, n = 12) were also fed NF or HF diets with high P (HP). 
Additionally, uremic (5/6Nx) rats (n = 16) were fed HP diets with NF or HF. Feeding the HF diets resulted 
in significant elevation of plasma FGF23 vs rats fed NF diets: Experiment 1, 593 ± 126 vs 157 ± 28 pg/
ml (p < 0.01); Experiment 2, 538 ± 105 vs 250 ± 18 pg/ml (p < 0.05); Experiment 3, 971 ± 118 vs 
534 ± 40 pg/ml (p < 0.01). Rats fed HF diets showed P retention and decreased renal klotho (ratio 
klotho/actin) vs rats fed NF diets: Experiment 1, 0.75 ± 0.06 vs 0.97 ± 0.02 (p < 0.01); Experiment 2, 
0.69 ± 0.07 vs 1.12 ± 0.08 (p < 0.01); Experiment 3, 0.57 ± 0.19 vs 1.16 ± 0.15 (p < 0.05). Uremic rats 
fed HF diet showed more severe vascular calcification (VC) than rats fed NF diet (aortic Ca = 6.3 ± 1.4 
vs 1.4 ± 0.1 mg/g tissue, p < 0.001). In conclusion, energy-rich diets increased plasma levels of 
FGF23, a known risk factor of cardiovascular morbidity and mortality. Even though FGF23 has major 
phosphaturic actions, feeding HF diets resulted in P retention, likely secondary to decreased renal 
klotho, and aggravated uremic VC.
Energy-dense foods (fast-foods) are implicated in the etiopathogenesis of dysmetabolic syndrome, a significant 
and growing health problem both in Western and developing countries1,2. In addition to their high caloric con-
tent, these foods are usually rich in phosphate (P), which is widely used as a food additive3,4. Moreover, the 
high fat content of fast-food is likely to increase P digestibility5, further aggravating P load. Phosphate overload 
may cause an increase in fibroblast growth factor 23 (FGF23), which is a known factor of cardiovascular risk6. 
Although there is an increasing awareness of the detrimental effects of the P content of fast-food, the influence of 
the caloric content of the diet on P balance has not been studied in detail.
Phosphate overload may be tolerated when renal function is intact; however, a decline in renal function, which 
is associated to high-fat intake and type II diabetes7, compromises P handling. In fact, in patients with chronic 
kidney disease (CKD), elevated serum phosphate plays a major role in the development of vascular calcifica-
tion (VC)8. Phosphate promotes VC through a series of mechanisms, including increased serum CaxP product, 
which leads to precipitation of calcium salts, and phenotypic transdifferentiation of vascular smooth muscle cells 
(VSMCs) to osteogenic cells9,10.
We hypothesized that feeding a diet with high caloric content (high fat diet) would cause an increase in FGF23 
in an attempt to control P balance, and would promote VC when renal function is impaired. Thus, the objectives 
of the present study were: (a) to evaluate changes in FGF23 and P balance induced by high fat diets in rats with 
normal and reduced renal function; and, (b) to investigate the influence of high fat diets on the development of 
VC in uremic rats.
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Results
Studies on P balance. Phosphorus balance was studied in rats with intact and reduced (1/2Nx) renal func-
tion fed diets with normal P (NP) and either normal fat (NF) or high fat (HF); and in rats with normal renal func-
tion fed high P (HP) diets with NF or HF. In all experiments, rats fed HF diets reduced their food intake when 
compared when rats fed NF diets. Therefore rats fed HF diets ingested less P than rats fed NF diets. However, the 
ingested P was more readily absorbed in rats fed HF diets than in rats fed NF diets. This resulted in almost the 
same net absorption of P and thus in a nearly identical P load in NF vs HF groups: rats with intact renal func-
tion fed NP, 44.5 ± 3.2 mg/day vs 44.1 ± 2.4 mg/day; 1/2Nx rats fed NP, 42.1 ± 1.6 mg/day vs 47.3 ± 2.0 mg/day; 
rats with intact renal function fed HP, 94.5 ± 6.5 mg/day vs 95.9 ± 4.2 mg/day. Urinary P excretion was not dif-
ferent in rats fed HF or NF and NP. In rats fed HP, P excretion by urine was lower (p < 0.05) in rats fed HF diet, 
85.0 ± 3.6 mg/day, than in rats fed NF diet, 101.3 ± 4.0 mg/day. In rats with intact renal function fed NP, a non-sig-
nificant tendency to P retention was detected with HF diet, 14.8 ± 1.8 mg/day vs 12.9 ± 2.2 mg/day in rats fed NF 
diet. Phosphorus retention in rats on HF diets became significant (p < 0.05) in 1/2Nx rats fed NP, 19.3 ± 1.8 mg/day 
vs 10.0 ± 2.2 mg/day in rats on NF diet, and in rats fed HP, 10.9 ± 4.4 mg/day vs − 6.8 ± 5.2 mg/day in rats on NF 
diet (Table 1).
In the groups receiving NP, even though P load was similar, rats fed HF diets showed consistently higher 
plasma FGF23 concentrations than rats fed NF diets: rats with intact renal function fed NP, 593 ± 126 pg/ml vs 
157 ± 28 pg/ml (p < 0.01), and 1/2Nx rats fed NP, 538 ± 105 pg/ml vs 250 ± 18 pg/ml (p < 0.05). Feeding a HP 
diet resulted in higher FGF23 levels than feeding NP diet and rats fed HP-HF diet also had significantly (p < 0.01) 
elevated FGF23, 995 ± 120 pg/ml, when compared with rats fed HP-NF diet, 547 ± 40 pg/ml (Fig. 1). HF diets 
elicited increased expression of FGF23 in bone. In a subset of rats fed NP, bone mRNA FGF23/GAPDH ratio 
increased 3 times in rats fed HF (n = 6) vs rats fed NF (n = 6) diets (3.6 ± 0.9 vs 1.1 ± 0.5, p < 0.05). It is interesting 
to note that even though plasma FGF23 concentrations were significantly higher in rats fed HF diets than in rats 
fed NF diets, urinary excretion of P was not increased in the animals fed HF diets (Table 1).
No significant differences between NF and HF groups were found in plasma concentrations of P, iCa, creati-
nine, total cholesterol, triglycerides and PTH. As expected, 1/2 Nx rats had higher plasma creatinine and urea. 
Similarly, rats fed HP tended to show higher PTH values. Plasma concentrations of calcidiol were similar in 
all groups and were not influenced by the increased caloric content in HF diets, except in rats fed HP-HF diet 
Experiment 1 Experiment 2 Experiment 3
NF (n = 6) HF (n = 6) NF (n = 6) HF (n = 6) NF (n = 6) HF (n = 6)
P Intake (mg/day) 93.06 ± 5.15 64.08 ± 3.16a 82.60 ± 3.73 66.24 ± 1.48a 156.40 ± 7.06 135.00 ± 5.08a
P Fecal Excretion (mg/day) 48.59 ± 2.32 20.02 ± 1.41a 43.04 ± 1.49 18.09 ± 1.93a 61.97 ± 3.42 39.03 ± 1.00a
P Net Absorption (mg/day) 44.47 ± 3.23 44.05 ± 2.44 42.14 ± 1.59 47.31 ± 2.04 94.46 ± 6.47 95.93 ± 4.22
P UrinaryExcretion (mg/day) 31.60 ± 1.79 29.25 ± 2.02 29.50 ± 1.82 30.64 ± 1.54 101.29 ± 4.03 85.04 ± 3.63a
P Balance (mg/day) 12.86 ± 2.18 14.79 ± 1.81 10.04 ± 2.24 19.34 ± 1.76a − 6.83 ± 5.17 10.90 ± 4.44a
Table 1.  Parameters related to phosphorus (P) balance in rats fed diets with normal fat (NF) and high 
fat (HF) content in Experiments 1–3. Experiment 1 (n = 12): rats with intact renal function fed 0.6% P, 
Experiment 2 (n = 12): 1/2Nx rats fed 0.6% P, Experiment 3 (n = 12): rats with intact renal function fed 1.2% P. 
ap < 0.05 vs NF in the same Experiment.
Figure 1. Influence of the fat content of the diet on fibroblast growth factor 23 (FGF23). Plasma 
concentrations of FGF23 in rats fed normal fat (NF, white bars) or high fat (HF, black bars) diets in the studies 
on P balance. Experiment 1 (n = 12): rats with intact renal function fed 0.6% P, Experiment 2 (n = 12): 1/2Nx 
rats fed 0.6% P, Experiment 3 (n = 12): rats with intact renal function fed 1.2% P. ap < 0.05 vs NF in the same 
Experiment, bp < 0.05 vs NF in Experiment 1.
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which had higher calcidiol. However, feeding HF diets resulted in significant reductions in plasma concentra-
tions of calcitriol when compared with rats fed NF diets: rats with intact renal function fed NP, 11.3 ± 1.1 pg/ml 
vs 82.2 ± 11.7 pg/ml (p < 0.001); 1/2Nx rats fed NP, 20.8 ± 10.8 pg/ml vs 117.1 ± 23.7 pg/ml (p < 0.01); rats with 
intact renal function fed HP, 74.8 ± 25.9 pg/ml vs 143.0 ± 11.8 pg/ml (p < 0.05) (Table 2).
Figure 2 shows the levels of klotho and FGFR1 proteins in the kidney. Changes in renal klotho were well corre-
lated with changes in plasma FGF23 concentrations. A significant decrease in renal klotho (ratio klotho/β -actin) 
was identified in all rats fed HF diets: rats with intact renal function fed NP, 0.75 ± 0.06 vs 0.97 ± 0.02 in rats fed 
NF diet (p < 0.01); 1/2Nx rats fed NP, 0.69 ± 0.07 vs 1.12 ± 0.08 in rats fed NF diet (p < 0.01); and rats with intact 
renal function fed HP, 0.57 ± 0.19 vs 1.16 ± 0.15 in rats fed NF diet (p < 0.05) (Fig. 2A). Feeding HF diets did not 
influence FGFR1 expression in the kidney (Fig. 2B).
Studies on vascular calcification (VC). Uremic rats fed HP-NF diet only experienced very minor mineral 
deposition in vascular tissue: aortic calcium = 1.4 ± 0.1 mg/g tissue, aortic phosphorus = 0.1 ± 0.1 mg/g tissue. 
However, 5/6 Nx rats on HP-HF diet showed consistent increases in both aortic calcium (6.3 ± 1.4 mg/g tissue) 
and phosphorus (12.4 ± 7.2 mg/g tissue), p < 0.001 vs NF diet. Similar results were obtained in other soft tis-
sues and extraskeletal calcification was also confirmed by von Kossa staining (Fig. 3). Feeding HF diets not only 
resulted in mineral deposition but also in a phenotypic transdifferentiation of the vessel wall that was evidenced 
by an increase in the expression of osteogenic genes. Thus, mRNA Runx-2/GAPDH ratio was increased by 2.8 
fold, mRNA Osterix/GAPDH was increased by 2.4 fold and mRNA Sclerostin/GAPDH was increased by 3.8 fold 
in rats fed HF diet when compared with rats fed NF diet (Fig. 4).
No differences between uremic rats fed NF and HF diets were observed in plasma creatinine, urea, iCa, P and 
PTH. Plasma triglycerides, LDL cholesterol and HDL cholesterol tended to be elevated in rats fed HF diet but 
significant differences with rats fed NF diet were only found in total cholesterol (111.9 ± 6.4 vs 84.2 ± 3.5 mg/dl). 
Plasma FGF23 was significantly higher (11,366 ± 1,639 vs 4,799 ± 2,402 pg/ml, p < 0.05) in rats fed HF diet 
(Table 3) and was correlated with aortic calcium (r = 0.640, p = 0.001). The increase in FGF23 was accompanied 
by a marked but non-significant decrease in the expression of klotho (ratio klotho/β -actin) in the remnant kidney 
of 5/6 Nx rats, from 1.00 ± 0.39 in rats fed NF diet to 0.55 ± 0.16 in rats fed HF diet.
Discussion
This study was designed to investigate the effect of feeding energy-dense diets on P balance and VC in rats with 
normal and reduced renal function. Our results show that rats fed diets with high fat content decreased renal 
klotho expression, developed P retention due to impaired renal excretion of P, and increased plasma FGF23 
concentrations. Moreover, uremic rats fed HF diets showed more severe VC than their normocaloric-fed 
counterparts.
The study experimental design was based on comparing the effect of diets with identical P concentration and 
different caloric content. For this purpose a high-fat diet, which is commercialized to induce obesity in rodents, 
was used. As previously reported11, during the experiments the rats fed HF diets reduced food consumption to 
maintain a constant caloric intake (around 50 kcal/day). Thus, after eating HF or NF diets for 30 days, no differ-
ences in body weight were observed between groups. This allowed to study the effect of the caloric content of the 
diet independent of obesity-mediated mechanisms (e.g. adipokines and other inflammatory mediators released 
by fat tissue). Although the reduction in food intake in rats fed HF diets resulted in a decreased P intake, in 
agreement with previous reports12 the intestinal absorption of P was increased in rats fed HF diets. The decrease 
in P intake was compensated by the increase in intestinal absorption of P in rats fed HF diets resulting in almost 
identical P load in HF vs NF groups.
Feeding HF diets was consistently associated to increases in plasma FGF23 concentrations in all experimental 
groups. Although FGF23 has been reported to be increased in obese people13 and a recent study identified energy 
intake as a potential predictor of plasma FGF23 concentrations14, to the best of our knowledge this is the first 
report demonstrating a direct relationship between ingestion of a high calories/high fat diet and increases in 
Experiment 1 Experiment 2 Experiment 3
NF (n = 6) HF (n = 6) NF (n = 6) HF (n = 6) NF (n = 6) HF (n = 6)
Creatinine (mg/dl) 0.58 ± 0.02 0.55 ± 0.02 0.66 ± 0.02b 0.72 ± 0.02b 0.57 ± 0.01 0.57 ± 0.01
Urea (mg/dl) 22.05 ± 2.75 20.28 ± 1.60 62.85 ± 4.55b 51.84 ± 5.97b 25.13 ± 2.07 22.94 ± 2.76
Triglycerides (mg/dl) 40.92 ± 5.44 45.11 ± 5.29 39.64 ± 4.61 40.78 ± 3.25 32.17 ± 4.17 40.50 ± 5.66
Total cholesterol (mg/dl) 50.21 ± 3.79 51.57 ± 2.80 48.11 ± 2.69 47.10 ± 2.92 44.71 ± 4.11 52.70 ± 2.92
iCalcium (mmol/l) 1.33 ± 0.01 1.35 ± 0.01 1.28 ± 0.01 1.27 ± 0.01 1.27 ± 0.01 1.26 ± 0.01
Phosphorus (mg/dl) 5.21 ± 0.33 5.93 ± 0.34 5.44 ± 0.21 5.66 ± 0.27 4.98 ± 0.26 6.19 ± 0.52
PTH (pg/ml) 16.99 ± 5.74 11.52 ± 2.88 23.86 ± 6.58 23.44 ± 7.66 25.31 ± 6.10 46.59 ± 14.57b
Calcidiol (ng/ml) 30.29 ± 2.33 25.65 ± 3.43 40.85 ± 4.52 42.17 ± 2.21 30.72 ± 2.87 64.34 ± 5.47a,b
Calcitriol (pg/ml) 82.19 ± 11.68 11.33 ± 1.11a 117.10 ± 23.70 20.78 ± 10.78a 143.00 ± 11.78 74.79 ± 25.92a
Table 2.  Blood biochemistry in rats fed diets with normal fat (NF) and high fat (HF) content in 
Experiments 1–3. Experiment 1 (n = 12): rats with intact renal function fed 0.6% P, Experiment 2 (n = 12): 
1/2Nx rats fed 0.6% P, Experiment 3 (n = 12): rats with intact renal function fed 1.2% P. ap < 0.05 vs NF in the 
same Experiment, bp < 0.05 vs NF in Experiment 1.
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plasma concentrations of FGF23. Circulating levels of FGF23 are a prognostic factor for cardiovascular disease 
in patients with CKD15 and in the general population16. Thus, the demonstration of elevated FGF23 after feeding 
energy dense diets provides additional insight into the deleterious effect of these diets on cardiovascular health.
One of the most intriguing findings of the present work is that the increase in FGF23 elicited by HF diets was 
not accompanied by an increase in renal excretion of P. These data strongly suggest resistance to the phosphaturic 
action of FGF23. To promote phosphaturia in the kidney tubule, FGF23 needs to bind to the klotho-FGFR com-
plex17. Therefore, the demonstration of reduced klotho protein levels in the kidneys of rats fed HF diet may explain 
the resistance to the phosphaturic action of FGF23 found in the present study. Renal klotho has been reported to 
be decreased in hyperlipidemic ApoE knockout mice and the authors suggested that hyperlipidemia-associated 
kidney injury might be responsible for the decreased renal expression of klotho18. While the renal toxicity of high 
fat diets is well documented19, additional mechanisms might be involved in the decrease of klotho induced by 
feeding HF diets. Klotho intervenes in energy regulation at different levels and klotho knockout mice display a 
lean phenotype20. Moreover, rats subjected to caloric restriction have been shown to increase renal klotho mRNA 
expression and klotho protein21. Thus, in addition to renal toxic effects, energy-dense diets may directly down-
regulate renal klotho. Klotho down-regulation by high caloric intake could have significant health consequences 
since, as shown in this study, it will lead to impaired renal excretion of P and P retention.
Feeding HF diets resulted in low plasma calcitriol concentrations and calcitriol was significantly lower in 
rats fed HF diets than in rats fed NF diets. The vitamin D content was identical in HF and NF diets. As explained 
above, the rats fed HF diets ingested less food and this might have resulted in decreased vitamin D intake; but, 
on the other hand, diets with high fat content have been reported to increase vitamin D absorption by the intes-
tine22. In any case, plasma calcidiol concentrations were not decreased in rats fed HF diets. Since calcidiol is the 
vitamin D metabolite that best reflects nutritional intake23, the origin of the decreased plasma calcitriol in rats 
fed HF diets cannot be attributed to decreased dietary intake of vitamin D. The most likely explanation for the 
decreased calcitriol is a reduction in calcitriol synthesis secondary to the increase in FGF23, which is known to 
inhibit the 1-alpha-hydroxylase activity in the kidney24. The decrease in serum calcitriol after eating diets with 
Figure 2. Influence of the fat content of the diet on renal klotho and fibroblast growth factor receptor 1 
(FGFR1). (A) Western Blots of klotho and (B) FGFR1 obtained from renal tissue of rats fed normal fat (NF, 
white bars) or high fat (HF, black bars) diets in the studies on P balance. Experiment 1 (n = 12): rats with intact 
renal function fed 0.6% P, Experiment 2 (n = 12): 1/2Nx rats fed 0.6% P, Experiment 3 (n = 12): rats with intact 
renal funcion fed 1.2% P. ap < 0.05 vs NF in the same Experiment.
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high fat content may also have significant health implications because vitamin D deficiency is associated with 
cardiovascular disease, diabetes and metabolic syndrome25,26.
Extraskeletal calcification is a common feature in uremic patients and VC represents an important contributor 
to the high rate of cardiovascular mortality associated to CKD8. The inability to eliminate P plays a major role 
in the development of uremic VC10. Data from Experiments 1–3 indicated that HF diets resulted in P retention 
particularly when rats were fed HP and, to a lesser extent, with moderate (1/2 Nx) reduction in renal function. 
In Experiment 4 we evaluated the effect of feeding HP-HF diets to uremic (5/6 Nx) rats. In contrast to rats fed 
HP-NF diets, uremic rats fed HP-HF diets showed upregulation of osteogenic genes in vascular tissue and marked 
VC. In addition to P retention, feeding HF diets also resulted in moderate dislipidemia which may also have con-
tributed to the development of VC. Our data demonstrate that although P retention associated to the ingestion 
Figure 3. Influence of the fat content of the diet on vascular calcification. (A) Calcium (white bars) and 
phosphorus (black bars) content (mg/g of tissue) in the aortas of uremic (5/6 Nx) rats fed high 1.2% P and either 
normal fat (NF, n = 6) or high fat (HF, n = 10) diets in Experiment 4. (B) Von Kossa stained sections of the 
aortas of 5/6Nx rats fed high 1.2% P and either NF (left) or HF (right). Calcification foci are stained in brown. 
ap < 0.05 vs NF.
Figure 4. Influence of the fat content of the diet on the expression of osteogenic genes in aortic tissue. 
Levels of mRNA Runx-2/GAPDH, mRNA Osterix/GAPDH and mRNA Sclerostin/GAPDH in the aortas of 
uremic (5/6 Nx) rats fed 1.2% P and either normal fat (NF, white bars) or high fat (HF, black bars) diets in 
Experiment 4 (n = 6 NF and 10 HF). ap < 0.05 vs NF.
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of fast-food can be tolerated when renal function is normal, in individuals with a significant decrease in renal 
function ingestion of high-fat diets may lead to VC.
In conclusion, after being fed with high fat diets rats showed decreased renal klotho expression, increased 
circulating levels of FGF23 and decreased plasma concentrations of calcitriol. Reduced klotho resulted in resist-
ance to the phosphaturic action of FGF23 and P retention. Moreover, uremic rats fed hypercaloric/high fat diets 
developed more severe extraosseous calcifications than their normocaloric-fed counterparts.
Methods
Ethics. All experimental protocols were reviewed and approved by the Ethics Committee for Animal Research 
of the University of Cordoba (Cordoba, Spain). All protocols were carried out in accordance with the approved 
guidelines. They followed the guidelines laid down by the Higher Council of Scientific Research of Spain follow-
ing the normal procedures directing animal welfare (Real Decreto 223/88, BOE of 18 of March) and adhered to 
the recommendations included in the Guide for Care and Use of Laboratory Animals (US Department of Health 
and Human Services, NIH) and European laws and regulations on protection of animals, under the advice of 
specialized personnel.
Animals, surgical procedures and diets. Three months-old Wistar rats, provided by the Animal 
Housing Facilities of the University of Cordoba (Cordoba, Spain), were housed with a 12 h/12 h light/dark cycle. 
Appropriate measures were taken to ensure animal welfare and to address the basic behavioral and physiological 
needs of rats. Renal function was reduced by either 1/2 nephrectomy (Nx) or 5/6 Nx. The former was performed 
by unilateral Nx while the 5/6 Nx was accomplished in a two-step procedure that reduces the original renal mass 
by five-sixths leading to uremia. These procedures are described in detail elsewhere27. Briefly, animals were anes-
thetized using xylazine (5 mg/kg, ip) and ketamine (80 mg/kg, ip). For the first step of the 5/6 Nx, a 5- to 8-mm 
incision was made on the left mediolateral surface of the abdomen. The left kidney was exposed, and the two 
poles (2/3 of renal mass) were ablated. The kidney was inspected and returned to an anatomically neutral position 
within the peritoneal cavity. The abdominal wall and skin incisions were closed with sutures, and the rat was 
placed back into its home cage. After 1 week of recovery, in the second step, the animal was reanesthetized and a 
5- to 8-mm incision was made on the right mediolateral surface of the abdomen. The right kidney was exposed 
and unencapsulated, the renal pedicle was clamped and ligated, and the kidney was removed. The ligated pedicle 
was returned to a neutral anatomical position and the abdomen and skin incisions closed with suture materials. 
The procedure for 1/2 Nx was identical to the second step of the 5/6 Nx. Phentanyl (0.2 mg/kg, ip) was used as 
analgesic agent.
Diets with two P concentrations were used in the experiments: normal P (0.6%) diet (NP) and high P 
(1.2%) diet (HP). Independent of their P content, diets had either a normal fat content (NF diet) with a 5% 
fat concentration that provided Metabolizable Energy = 3518 kcal/kg (Altromin C 1000, AltrominSpezialfutter 
GmbH, Germany) or a high fat content (HF diet) with a 35% fat concentration that provided Metabolizable 
Energy = 5241 kcal/kg (Altromin C 1090–60, AltrominSpezialfutter GmbH, Germany). All diets had 0.6% of Ca 
and 500 IU/g of vitamin D.
Experimental Design
Studies on P balance. These experiments were conducted with the rats housed in metabolic cages, allowing 
daily control of food and water intake and collection of urine and feces. During the first week the animals were 
adapted to the cages and received the control diet with 0.6% P and normal fat (NP-NF). Then, rats were switched 
to experimental diets in three Experiments:
Experiment 1- Rats with intact renal function were allotted to 2 groups (n = 6 each). Rats in group 1 were fed 
normal P and normal fat diet (NP-NF) and rats in group 2 were fed normal P and high fat diet (NP-HF) for 30 
days. Water and food intake were recorded daily during the whole experiment. During the last week of the trial 
feces and urine were collected daily to assess P balance. At day 30, rats were sacrificed by exsanguination under 
general anesthesia (thiopental, 20 mg/kg, ip) to obtain blood and tissue samples.
Experiment 4
NF (n = 6) HF (n = 10)
Creatinine (mg/dl) 0.91 ± 0.09 1.01 ± 0.10
Urea (mg/dl) 88.56 ± 30.51 80.02 ± 8.72
Triglycerides (mg/dl) 44.71 ± 10.15 58.11 ± 13.88
Total cholesterol (mg/dl) 84.15 ± 3.51 111.88 ± 6.41a
LDL cholesterol (mg/dl) 15.68 ± 3.11 18.35 ± 2.06
HDL cholesterol (mg/dl) 37.51 ± 8.39 45.87 ± 3.89
iCalcium (mmol/l) 1.09 ± 0.03 1.11 ± 0.01
Phosphorus (mg/dl) 6.1 ± 1.4 7.8 ± 1.2
FGF23 (pg/ml) 4,799 ± 2,402 11,366 ± 1,639a
PTH (pg/ml) 468 ± 116 476 ± 54
Table 3.  Blood biochemistry in uremic (5/6 Nx) rats fed 1.2% P and either normal fat (NF) or high fat (HF) 
diets in Experiment 4. ap  <  0.05 vs NF.
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Experiment 2- Rats with reduced (1/2 Nx) renal function (n = 12) were fed either normal P and normal fat 
(NP-NF, n = 6) or normal P and high fat (NP-HF, n = 6) diet for 30 days, following the same protocol as in 
Experiment 1.
Experiment 3- Rats with intact renal function were fed HP diet (1.2% P) and were allotted to 2 groups (n = 6 
each). Rats in group 1 were fed normal fat diet (HP-NF) and rats in group 2 were fed high fat diet (HP-HF) for 30 
days, following the same protocol as in Experiments 1 and 2.
Studies on vascular calcification (VC). These studies (Experiment 4) were aimed at evaluating the effect 
of feeding HF diet on the development of VC in uremic rats. Sixteen rats were fed a NP diet with either normal fat 
content (NP-NF, n = 6) or high fat content (NP-HF, n = 10) for 45 days. At day 45 the first step of the 5/6 Nx was 
conducted and a week later the 5/6Nx was completed (day 52). After the second step of 5/6 Nx rats were switched 
to a HP (1.2%) diet. The fat content of the diet was maintained unchanged; thus rats received HP-NF (n = 6) or 
HP-HF (n = 10) diets. Rats were sacrificed at day 112 to obtain blood and tissue samples.
Blood chemistries. Blood for chemistry analyses was obtained at the time of sacrifice (intraperitoneal thi-
opental anesthesia plus exsanguination), from the abdominal aorta. Blood for measurements of ionized calcium 
levels was collected in heparinized syringes and immediately analyzed using a Ciba-Corning 634 ISE Ca2+/pH 
Analyzer (Ciba-Corning, Essex, England). Afterwards, plasma was separated by centrifugation and stored at 
− 20 °C until assayed. Plasma creatinine, urea, tryglycerides, total cholesterol, HDL cholesterol, LDL cholesterol 
and phosphorus were measured by spectrophotometry (BioSystems SA, Barcelona, Spain). ELISA tests were 
used to quantify plasma FGF23 (Kainos Laboratories, Tokyo, Japan) and PTH (Immutopics, San Clemente, CA). 
Radioimmunoassay (Immunodiagnostic Systems Ltd, Boldon, UK) was used in plasma samples to determine 
25-hydroxyvitamin D (calcidiol) and 1,25-dihydroxyvitamin D (calcitriol).
Urine and feces analysis. Fecal samples were dried, ashed and demineralized with 0.6 mmol/l HNO3 solu-
tion. Fecal P was measured by inductively coupled plasma mass spectrophotometry (ICP-MS, Perkin Elmer Elan 
DRC-e, Walthan, Massachusetts, USA). Urinary phosphorus was measured by spectrophotometry (BioSystems 
SA, Barcelona, Spain). Net intestinal absorption (equation (1)) and P balance (equation (2)) were calculated as 
follows:
= −P net absorption (mg/day) P intake P fecal excretion (1)
= −P balance mg/day P net absorption P urinary excretion (2)
Protein extraction and Western blot analysis. Proteins were isolated from renal tissue by using a 
lysis buffer containing HEPES (10 mmol/l), KCl (10 mmol/l), EDTA (0.1 mmol/l), EGTA (0.1 mmol/l), DTT 
(1 mmol/l), PMSF (0.5 mmol/l), protease inhibitor cocktail (70 μ g/ml), and I-Gepal CA-630 (0.6%), pH 7.9 
(Sigma Aldrich, St. Louis, MO). Protein concentration was determined by Bradford method. For Western Blot 
analysis, 50 μ g of protein were electrophoresed on a 10% SDS-polyacrilamide gel (Invitrogen, Carlsbad, CA) 
and electrophoretically transferred (Transfer Systems, BioRad, Hercules, CA) from the gels onto nitrocellulose 
membranes (Invitrogen). The following steps were perfomed with gentle shaking. Membranes were incubated in 
TTBS-L solution [20 mMTris-HCl (pH 7.6), 0.2% Tween 20, 150 mMNaCl] (Sigma Aldrich), and 5% nonfat dry 
milk (Bio-Rad) at room temperature for 1 hour to avoid nonspecific binding. Membranes were then washed with 
TTBS buffer (the same composition as TTBS-L without nonfat dry milk) and incubated for 2 hours at room tem-
perature with a mouse anti-FGFR1 antibody (GeneTex, Irvine, CA; 0.5 μ g/ml) or rat anti-klotho antibody (Alpha 
Diagnostic Int, San Antonio, TX; 0.5 μ g/ml). The membranes were then washed with TTBS buffer and inmuno-
labeled using a peroxidase-conjugated secondary antibody (1:5000 dilution; Santa Cruz Biotechnology Inc, Santa 
Cruz, CA). Finally, they were revealed on autoradiographic film using ECL Plus Western Blotting Detection 
System (GE Healthcare, Piscataway, NJ). Beta-Actin was used as housekeeping protein to ensure equal loading 
of the gels. Protein levels were quantified using ImageJ software (National Institutes of Health, Bethesda, MD).
Real-Time-Polymerase Chain Reaction (RT-PCR). Study of bone FGF23 and aortic Runx-2, Osterix 
and Sclerostin mRNA was performed by Quantitative Real-Time PCR. Tibial bone or aorta were disrupted using 
liquid nitrogen and grinded thoroughly with a mortar. Aortic total RNA was extracted from the lysate using RNA 
extraction kit (RNeasy Fibrous Tissue Mini Kit, Qiagen, Germany). Bone RNA was extracted using the chloro-
form and isopropanol precipitation method and a treatment with DNAse I Amplification Grade (Sigma-Aldrich). 
Fifty ng of total RNA were used to analyze mRNA expression in the LightCycler thermal cycler system (Roche 
Diagnostics, Indianapolis, IN, USA). RT-PCR was performed in one step, using the QuantiTect SYBR Green 
RT-PCR kit (Qiagen GmbH, Hilden, Germany) following the manufacturer’s protocol. Primers for Runx-2, 
Osterix and GAPDH were designed with the free Oligo 7 software. The Sclerostin primer was purchased to 
Integrated DNA Technologies, Inc (San Diego, CA, USA). Primer sequences are listed below:
FGF23- F: 5′ -TTGGATCGTATCACTTCAGC-3′ ,
R: 5′ -TGCTTCGGTGACAGGTAG-3′ ;
Runx-2- F: 5′ -CGG GAATGATGAGAACTACTC-3′ ,
R: 5′ -GCG GTCAGAGAACAAACTAGGT-3′ ;
Osterix- F: 5′ -GTACGGCAAGGCTTCGCATCTGA-3′ ,
R: 5′ -TCAAGTGGTCGCTTCGGGTAAAG-3′ ;
GAPDH- F: 5′ -AGGGCTGCCTTCTCTTGTGAC-3′ ,
R: 5′ -TGGGTAGAATCATACTGGAACATGTAG-3′ .
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The expression of target genes was normalized to GAPDH as housekeeping and calculated according to the 
2∆ (∆ CT) method.
Assessment of vascular calcification (VC). Following sacrifice, the thoracic aorta, stomach and lungs 
were dissected and processed to study mineral content. Calcification was studied by measuring the tissue calcium 
and phosphorus content. The tissues were demineralized in 10% formic acid (aorta) and 150 mM HCl (stomach 
and lungs). The calcium and phosphorus content was measured in the supernatant according to a method previ-
ously described27. Fresh tissue was also fixed in 10% buffered formalin, embedded in paraffin, and cut into 3 μ m 
sections. Paraffin-embedded sections of the aorta, lung and stomach were stained by the Von Kossa method to 
evaluate mineralization.
Statistics. Values are expressed as the mean ± standard error (SE). The difference between means for two 
different groups was determined by t-test; the difference between means for three or more groups was assessed by 
ANOVA. Fisher LSD test was used as a post-hoc procedure. A correlation study was carried out using the Pearson 
test. p < 0.05 was considered significant.
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